Scancell Holdings Plc Company Profile (LON:SCLP)

About Scancell Holdings Plc (LON:SCLP)

Scancell Holdings Plc logoScancell Holdings plc is a biopharmaceutical company focused on the cancer therapeutics market. The Company's principal activity consists of the discovery and development of monoclonal antibodies and vaccines for the treatment of cancer. The Company is developing a pipeline of immunotherapies for the treatment of cancer based on its ImmunoBody and Moditope platforms. The Company's products include SCIB1, SCIB2 and Modi-1. The Company's first cancer vaccine, SCIB1, is being developed for the treatment of melanoma and is in Phase I/II clinical trials. SCIB2 contains multiple T cell epitopes derived from the lung cancer associated antigen NY-ESO-1. It is developed to the point at which the product is defined and ready for further preclinical development as an immunotherapy for any tumor that expresses the NY-ESO-1 antigen. The Company's first Moditope development candidate is Modi-1. Modi-1 consists of two citrullinated vimentin peptides and one citrullinated enolase peptide.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: LON:SCLP
  • CUSIP: N/A
  • Web: N/A
Capitalization:
  • Market Cap: £28.12 million
  • Outstanding Shares: 261,558,000
Average Prices:
  • 50 Day Moving Avg: GBX 12.63
  • 200 Day Moving Avg: GBX 14.17
  • 52 Week Range: GBX 9.68 - GBX 21.36
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.0000
Sales & Book Value:
  • Annual Revenue: N/A
  • Price / Sales: N/A
  • Book Value: GBX 0.03 per share
  • Price / Book: 3.58
Profitability:
  • EBIDTA: ($3,770,000.00)
Misc:
  • Average Volume: 179,290 shs.
 

Frequently Asked Questions for Scancell Holdings Plc (LON:SCLP)

What is Scancell Holdings Plc's stock symbol?

Scancell Holdings Plc trades on the London Stock Exchange (LON) under the ticker symbol "SCLP."

Where is Scancell Holdings Plc's stock going? Where will Scancell Holdings Plc's stock price be in 2017?

1 brokers have issued 1 year price objectives for Scancell Holdings Plc's shares. Their predictions range from GBX 68 to GBX 68. On average, they anticipate Scancell Holdings Plc's share price to reach GBX 68 in the next twelve months. View Analyst Ratings for Scancell Holdings Plc.

Who are some of Scancell Holdings Plc's key competitors?

How do I buy Scancell Holdings Plc stock?

Shares of Scancell Holdings Plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How much does a share of Scancell Holdings Plc stock cost?

One share of Scancell Holdings Plc stock can currently be purchased for approximately GBX 10.75.

Analyst Ratings

Consensus Ratings for Scancell Holdings Plc (LON:SCLP) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: GBX 68

Analysts' Ratings History for Scancell Holdings Plc (LON:SCLP)
Show:
DateFirmActionRatingPrice TargetDetails
4/20/2017Panmure GordonReiterated RatingBuyGBX 68View Rating Details
(Data available from 5/23/2015 forward)

Earnings

Earnings History for Scancell Holdings Plc (LON:SCLP)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Scancell Holdings Plc (LON:SCLP)
Current Year EPS Consensus Estimate: $-1.20 EPS

Dividends

Dividend History for Scancell Holdings Plc (LON:SCLP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Scancell Holdings Plc (LON:SCLP)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Scancell Holdings Plc (LON:SCLP)
Latest Headlines for Scancell Holdings Plc (LON:SCLP)
Source:
DateHeadline
americanbankingnews.com logoScancell Holdings Plc (SCLP) Earns Buy Rating from Panmure Gordon
www.americanbankingnews.com - April 20 at 7:37 PM
americanbankingnews.com logoScancell Holdings Plc (SCLP) Given Buy Rating at Panmure Gordon
www.americanbankingnews.com - April 16 at 9:44 AM
finance.yahoo.com logoScancell’s (SCLP.L )Addario Lung Cancer Collaboration
finance.yahoo.com - March 17 at 7:48 PM
biz.yahoo.com logoHalf Year 2017 Scancell Holdings PLC Earnings Release - Before Market Open
biz.yahoo.com - January 31 at 10:43 PM
finance.yahoo.com logoSCLP: A Vanguard in Cancer Vaccines: 2 Platforms, 3 Products, 5 Indications
finance.yahoo.com - January 31 at 10:43 PM
lse.co.uk logoScancell Holdings Regulatory News
www.lse.co.uk - January 3 at 9:46 AM
lse.co.uk logoResults of AGM - London South East (registration) (blog)
www.lse.co.uk - October 18 at 7:04 PM

Social

Social activity is not available for this stock.

Chart

Scancell Holdings Plc (SCLP) Chart for Tuesday, May, 23, 2017

This page was last updated on 5/23/2017 by MarketBeat.com Staff